Tag: lab automation in drug discovery market analysis

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Lab Automation In Drug Discovery Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The lab automation in drug discovery market has experienced significant expansion in recent years. It is projected to grow from $6.77 billion in 2025 to $7.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. The historical increase in this market can be attributed to several factors, including the adoption of robotic arms in laboratories, rising investment in pharmaceutical research and development, an increased demand for automation to minimize errors, the integration of lab information management systems, and the growth in high-throughput screening technologies.

The lab automation in drug discovery market is projected for substantial expansion in the coming years. It is anticipated to reach $8.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.2%. This expected growth during the forecast period is driven by several factors, including the expansion of AI-driven drug discovery platforms, a growing demand for personalized medicine, the emergence of cloud-based lab management solutions, the adoption of advanced robotics for sample handling, and increasing collaborations between pharmaceutical and biotechnology companies. Prominent trends anticipated in this period feature high-throughput screening automation, integrated laboratory workflows, the use of predictive analytics in drug discovery, the miniaturization of lab processes, and cloud-based lab management.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=57903064&type=smp&name=Lab%20Automation%20In%20Drug%20Discovery%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lab Automation In Drug Discovery Market Growth Factors: What’s Supporting Expansion?

The escalating need for precision medicine is projected to stimulate the expansion of lab automation within the drug discovery market moving forward. Precision medicine, also known as personalized medicine, is a method for medical treatment and prevention that considers the unique variations in genes, environment, and lifestyle for each person. Lab automation quickens research, enhances experimental consistency, and improves the efficiency of precision medicine and drug discovery workflows, ultimately contributing to the development of more effective medications and diagnostics tailored for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized therapies for patients with rare diseases, which was a considerable increase from the six approved in 2022. Thus, the heightened demand for precision medicine is propelling the growth of lab automation in the drug discovery market.

Lab Automation In Drug Discovery Market Segment Landscape: Which Areas Lead Development?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Lab Automation In Drug Discovery Market Industry Trends: What’s Reshaping Demand?

Major companies engaged in lab automation within the drug discovery market are focusing on integrating AI-driven and robotics-based platforms to accelerate formulation development and improve R&D efficiency. These AI-powered and robot-assisted platforms leverage smart algorithms and automated machines to streamline tasks, enhance precision, and speed up workflows. For example, in May 2025, Intrepid Labs, a research laboratory based in Canada, launched its Valiant platform, an AI-driven and robotics-enabled system engineered to dramatically accelerate drug formulation development. Backed by over $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company intends to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant autonomously explores entire formulation design spaces, reducing timelines from months to days while simultaneously improving therapeutic performance and safety. Since its founding in 2023, Intrepid Labs has secured partnerships with major pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.

Lab Automation In Drug Discovery Market Industry Leaders And Competitive Landscape

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

View The Full Lab Automation In Drug Discovery Market Report:

https://thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lab Automation In Drug Discovery Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Lab Automation In Drug Discovery Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The lab automation in drug discovery market has experienced significant expansion in recent years. It is projected to grow from $6.77 billion in 2025 to $7.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. The historical increase in this market can be attributed to several factors, including the adoption of robotic arms in laboratories, rising investment in pharmaceutical research and development, an increased demand for automation to minimize errors, the integration of lab information management systems, and the growth in high-throughput screening technologies.

The lab automation in drug discovery market is projected for substantial expansion in the coming years. It is anticipated to reach $8.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.2%. This expected growth during the forecast period is driven by several factors, including the expansion of AI-driven drug discovery platforms, a growing demand for personalized medicine, the emergence of cloud-based lab management solutions, the adoption of advanced robotics for sample handling, and increasing collaborations between pharmaceutical and biotechnology companies. Prominent trends anticipated in this period feature high-throughput screening automation, integrated laboratory workflows, the use of predictive analytics in drug discovery, the miniaturization of lab processes, and cloud-based lab management.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=57903064&type=smp&name=Lab%20Automation%20In%20Drug%20Discovery%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lab Automation In Drug Discovery Market Growth Factors: What’s Supporting Expansion?

The escalating need for precision medicine is projected to stimulate the expansion of lab automation within the drug discovery market moving forward. Precision medicine, also known as personalized medicine, is a method for medical treatment and prevention that considers the unique variations in genes, environment, and lifestyle for each person. Lab automation quickens research, enhances experimental consistency, and improves the efficiency of precision medicine and drug discovery workflows, ultimately contributing to the development of more effective medications and diagnostics tailored for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized therapies for patients with rare diseases, which was a considerable increase from the six approved in 2022. Thus, the heightened demand for precision medicine is propelling the growth of lab automation in the drug discovery market.

Lab Automation In Drug Discovery Market Segment Landscape: Which Areas Lead Development?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Lab Automation In Drug Discovery Market Industry Trends: What’s Reshaping Demand?

Major companies engaged in lab automation within the drug discovery market are focusing on integrating AI-driven and robotics-based platforms to accelerate formulation development and improve R&D efficiency. These AI-powered and robot-assisted platforms leverage smart algorithms and automated machines to streamline tasks, enhance precision, and speed up workflows. For example, in May 2025, Intrepid Labs, a research laboratory based in Canada, launched its Valiant platform, an AI-driven and robotics-enabled system engineered to dramatically accelerate drug formulation development. Backed by over $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company intends to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant autonomously explores entire formulation design spaces, reducing timelines from months to days while simultaneously improving therapeutic performance and safety. Since its founding in 2023, Intrepid Labs has secured partnerships with major pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.

Lab Automation In Drug Discovery Market Industry Leaders And Competitive Landscape

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

View The Full Lab Automation In Drug Discovery Market Report:

https://thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lab Automation In Drug Discovery Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Lab Automation In Drug Discovery Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The lab automation in drug discovery market has experienced significant expansion in recent years. It is projected to grow from $6.77 billion in 2025 to $7.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. The historical increase in this market can be attributed to several factors, including the adoption of robotic arms in laboratories, rising investment in pharmaceutical research and development, an increased demand for automation to minimize errors, the integration of lab information management systems, and the growth in high-throughput screening technologies.

The lab automation in drug discovery market is projected for substantial expansion in the coming years. It is anticipated to reach $8.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.2%. This expected growth during the forecast period is driven by several factors, including the expansion of AI-driven drug discovery platforms, a growing demand for personalized medicine, the emergence of cloud-based lab management solutions, the adoption of advanced robotics for sample handling, and increasing collaborations between pharmaceutical and biotechnology companies. Prominent trends anticipated in this period feature high-throughput screening automation, integrated laboratory workflows, the use of predictive analytics in drug discovery, the miniaturization of lab processes, and cloud-based lab management.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=57903064&type=smp&name=Lab%20Automation%20In%20Drug%20Discovery%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lab Automation In Drug Discovery Market Growth Factors: What’s Supporting Expansion?

The escalating need for precision medicine is projected to stimulate the expansion of lab automation within the drug discovery market moving forward. Precision medicine, also known as personalized medicine, is a method for medical treatment and prevention that considers the unique variations in genes, environment, and lifestyle for each person. Lab automation quickens research, enhances experimental consistency, and improves the efficiency of precision medicine and drug discovery workflows, ultimately contributing to the development of more effective medications and diagnostics tailored for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized therapies for patients with rare diseases, which was a considerable increase from the six approved in 2022. Thus, the heightened demand for precision medicine is propelling the growth of lab automation in the drug discovery market.

Lab Automation In Drug Discovery Market Segment Landscape: Which Areas Lead Development?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Lab Automation In Drug Discovery Market Industry Trends: What’s Reshaping Demand?

Major companies engaged in lab automation within the drug discovery market are focusing on integrating AI-driven and robotics-based platforms to accelerate formulation development and improve R&D efficiency. These AI-powered and robot-assisted platforms leverage smart algorithms and automated machines to streamline tasks, enhance precision, and speed up workflows. For example, in May 2025, Intrepid Labs, a research laboratory based in Canada, launched its Valiant platform, an AI-driven and robotics-enabled system engineered to dramatically accelerate drug formulation development. Backed by over $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company intends to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant autonomously explores entire formulation design spaces, reducing timelines from months to days while simultaneously improving therapeutic performance and safety. Since its founding in 2023, Intrepid Labs has secured partnerships with major pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.

Lab Automation In Drug Discovery Market Industry Leaders And Competitive Landscape

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

View The Full Lab Automation In Drug Discovery Market Report:

https://thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lab Automation In Drug Discovery Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Lab Automation In Drug Discovery Market Forecast Highlighting Growth From $7.11 Billion To $8.71 Billion

The market for lab automation in drug discovery has experienced robust expansion over the past few years. Projected to rise from $6.77 billion in 2025 to $7.12 billion in 2026, it reflects a compound annual growth rate (CAGR) of 5.1%. This historical growth has been driven by several factors, including the deployment of robotic arms in laboratory settings, heightened expenditure on pharmaceutical research and development, a growing need for error-reducing automation, the incorporation of lab information management systems, and advances in high-throughput screening methods.

The laboratory automation sector within drug discovery is anticipated to experience significant expansion over the coming years. By 2030, the market value is projected to reach $8.72 billion, reflecting a compound annual growth rate (CAGR) of 5.2%. This projected growth during the forecast period is driven by several key factors, including the rise of AI-enhanced drug discovery platforms, a heightened need for personalized therapeutics, the growing implementation of cloud-based laboratory management systems, the adoption of sophisticated robotics for sample processing, and an increase in strategic alliances between pharmaceutical and biotechnology firms. Among the pivotal trends shaping this period are the automation of high-throughput screening, the creation of integrated laboratory workflows, the application of predictive analytics in the discovery process, the downsizing of laboratory procedures, and the management of labs via cloud-based solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Lab Automation In Drug Discovery Market Growth Momentum: Which Factors Are Influencing Demand?

The growing demand for personalized medicine is anticipated to drive advancements in laboratory automation within the drug discovery sector. This approach, often referred to as tailored therapy, customizes medical prevention and treatment by factoring in each person’s unique genetic, environmental, and lifestyle differences. By speeding up research, enhancing experimental reproducibility, and boosting the overall efficiency of precision medicine and drug development processes, lab automation facilitates the creation of more effective drugs and diagnostics designed for individual patients. As an example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit, noted that the FDA approved 16 new personalized treatments for rare diseases in 2023—a substantial jump from the six approvals seen in 2022. Thus, the escalating need for precision medicine is fueling the expansion of lab automation in the drug discovery market.

Lab Automation In Drug Discovery Market Segment Outlook: Which Categories Are Expanding The Fastest?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Lab Automation In Drug Discovery Market Trends Reshaping Industry Growth

Major pharmaceutical firms in the lab automation segment of the drug discovery market are increasingly prioritising the incorporation of AI-driven and robotics-based systems to accelerate formulation development while boosting overall research and development productivity. Such AI-enhanced and robot-assisted platforms leverage sophisticated algorithms and automated machinery to improve task execution, elevate accuracy, and expedite operational workflows. As a notable illustration in May 2025, Intrepid Labs, a research laboratory based in Canada, officially introduced its Valiant platform—a system driven by artificial intelligence and robotics that is engineered to significantly fast-track drug formulation processes. Backed by over $11 million in total funding, which includes a recent $7 million seed round spearheaded by AVANT Bio, this initiative is designed to replace conventional slow and trial-driven formulation methods with rapid and data-informed optimisation approaches. The Valiant platform autonomously explores complete formulation design spaces, compressing timelines from months to just days while simultaneously enhancing both therapeutic efficacy and safety profiles. Since its establishment in 2023, Intrepid Labs has managed to forge collaborations with major pharmaceutical companies and contract research organisations, while also advancing proprietary oral and long-acting injectable technologies available for licensing.

Lab Automation In Drug Discovery Market Key Companies And Competitive Benchmarking

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

Access The Complete Lab Automation In Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Lab Automation In Drug Discovery Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Lab Automation In Drug Discovery Market During 2026–2030?

The lab automation in drug discovery market size has shown significant expansion in recent years. It is anticipated to grow from $6.77 billion in 2025 to $7.12 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.1%. The growth observed in previous periods is largely due to factors such as the adoption of robotic arms in laboratories, increased investment in pharmaceutical research and development, a heightened demand for automation to reduce errors, the integration of lab information management systems, and the progression of high-throughput screening technologies.

The lab automation in drug discovery market is anticipated to experience strong growth in the coming years. It is projected to reach $8.72 billion in 2030, with a compound annual growth rate (CAGR) of 5.2%. This growth in the forecast period is attributed to the expansion of AI-driven drug discovery platforms, the increasing demand for personalized medicine, the development of cloud-based lab management solutions, the adoption of advanced robotics for sample handling, and rising collaborations between pharma and biotech companies. Key trends in the forecast period include high-throughput screening automation, integrated laboratory workflows, predictive analytics in drug discovery, miniaturization of lab processes, and cloud-based lab management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

Which Drivers Are Advancing The Lab Automation In Drug Discovery Market Growth?

Growing requirements for precision medicine are projected to boost the expansion of lab automation within the drug discovery market moving ahead. Precision medicine, interchangeably referred to as personalized medicine, represents a medical treatment and prevention strategy that considers each person’s unique variations in genes, environment, and lifestyle. Lab automation speeds up research, enhances the reproducibility of experiments, and boosts the efficiency of procedures in precision medicine and drug discovery, which ultimately results in the development of more effective medications and diagnostic tools tailored for individual patients. For example, the US-based non-profit organization, Personalized Medicine Coalition, disclosed in February 2024 that the FDA had sanctioned 16 novel personalized treatments for rare disease patients in 2023, marking a considerable rise from the six approved in 2022. Consequently, the rising need for precision medicine is fueling the expansion of lab automation in the drug discovery market.

How Is The Lab Automation In Drug Discovery Market Distributed Across Key Segments?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Which Trends Are Expected To Shape The Lab Automation In Drug Discovery Market?

Leading companies engaged in the lab automation segment within the drug discovery market are prioritizing the integration of AI-driven and robotics-based platforms to expedite formulation development and elevate R&D efficiency. These AI-powered and robot-assisted platforms employ intelligent algorithms and automated machines to streamline operations, enhance precision, and accelerate workflows. For example, in May 2025, Intrepid Labs, a Canada-based research laboratory, launched its Valiant platform, which is an AI-driven and robotics-enabled system designed to significantly speed up drug formulation development. With over $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company aims to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant autonomously explores entire formulation design spaces, cutting timelines from months to days while simultaneously boosting therapeutic performance and safety. Since its founding in 2023, Intrepid Labs has established partnerships with key pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.

Which Key Players Are Active In The Lab Automation In Drug Discovery Market?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

Access The Complete Lab Automation In Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Which Region Contributes The Most To The Lab Automation In Drug Discovery Market?

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Lab Automation In Drug Discovery Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2026, By The Business Research Company

Lab Automation In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Lab Automation In Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-genomics-global-market-report

Lab Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Lab Automation In Drug Discovery Market Over The 2026–2030 Period?

The lab automation in drug discovery market size has experienced strong growth in recent years. It is forecast to grow from $6.77 billion in 2025 to $7.12 billion in 2026, at a compound annual growth rate (CAGR) of 5.1%. This historical expansion can be attributed to factors such as the increasing adoption of robotic arms in laboratories, rising investment in pharmaceutical research and development, a greater demand for automation to reduce errors, the integration of lab information management systems, and advancements in high-throughput screening technologies.

The market size for lab automation in drug discovery is anticipated to show robust expansion in the coming years. It is forecast to grow to $8.72 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.2%. The progress during the forecast period is attributable to several factors, including the expansion of AI-driven drug discovery platforms, an increasing demand for personalized medicine, the rise of cloud-based lab management solutions, the adoption of advanced robotics for sample handling, and increasing collaborations between pharma and biotech companies. Key trends for the forecast period include high-throughput screening automation, integrated laboratory workflows, the application of predictive analytics in drug discovery, the miniaturization of lab processes, and cloud-based lab management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

What Primary Drivers Are Shaping The Lab Automation In Drug Discovery Market?

The expanding need for precision medicine is predicted to drive the expansion of lab automation within the drug discovery sector in the coming years. This approach, sometimes called personalized medicine, focuses on medical treatment and prevention by factoring in each individual’s distinct genetic traits, environmental conditions, and lifestyle. Automation in laboratories speeds up research, boosts the consistency of experiments, and makes precision medicine and drug discovery processes more effective, resulting in better drugs and diagnostics customized for individual patients. For example, the Precision Medicine Coalition, a US-based non-profit organization, published a report in February 2024 indicating that 16 new personalized treatments for patients with rare diseases received FDA approval in 2023, representing a notable increase compared to the six approved in 2022. Consequently, the rising requirement for precision medicine is a key factor boosting the development of lab automation in the drug discovery market.

Which Segment Types Are Examined In The Lab Automation In Drug Discovery Market Segment Study?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

What Trends Are Affecting The Direction Of The Lab Automation In Drug Discovery Market?

Major companies engaged in lab automation within the drug discovery market are prioritizing the integration of AI-driven and robotics-based platforms to speed up formulation development and boost R&D efficiency. These AI-powered and robot-assisted platforms utilize smart algorithms and automated machines to streamline operations, increase precision, and accelerate workflows. For example, in May 2025, Intrepid Labs, a Canada-based research laboratory, launched its Valiant platform, an AI-driven and robotics-enabled system crafted to dramatically accelerate drug formulation development. Supported by more than $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company intends to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant autonomously explores full formulation design spaces, reducing timelines from months to days while simultaneously improving therapeutic performance and safety. Since its 2023 founding, Intrepid Labs has established partnerships with major pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.

Which Players Are Part Of The Competitive Landscape Of The Lab Automation In Drug Discovery Market?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

Get The Full Lab Automation In Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Which Region Accounts For The Largest Portion Of The Lab Automation In Drug Discovery Market?

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lab Automation In Drug Discovery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2026, By The Business Research Company

Lab Automation In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Lab Automation In Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-genomics-global-market-report

Lab Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Lab Automation In Drug Discovery Market Evolve From 2026 To 2030?

The lab automation in drug discovery market size has experienced substantial growth in recent years. It is projected to increase from $6.77 billion in 2025 to $7.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. This historical expansion can be attributed to factors such as the adoption of robotic arms in laboratories, rising investment in pharmaceutical R&D, a greater need for automation to reduce errors, the integration of lab information management systems, and the development of high-throughput screening technologies.

The lab automation in drug discovery market is projected for significant expansion in the coming years. This market is set to reach $8.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. This growth during the projection period stems from factors such as the proliferation of AI-driven drug discovery platforms, a rising need for personalized medicine, the development of cloud-based lab management solutions, the integration of advanced robotics for sample handling, and increasing partnerships between pharmaceutical and biotechnology firms. Key trends during this period are expected to encompass high-throughput screening automation, streamlined integrated laboratory workflows, the application of predictive analytics in drug discovery, the miniaturization of laboratory procedures, and cloud-based lab management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

What Major Drivers Are Influencing Demand In The Lab Automation In Drug Discovery Market?

The rising need for precision medicine is anticipated to fuel the expansion of lab automation within the drug discovery market moving ahead. Precision medicine, interchangeably referred to as personalized medicine, represents a medical strategy for treatment and prevention that considers unique variations in an individual’s genetic makeup, surroundings, and way of life. Through lab automation, research is expedited, experimental reproducibility is enhanced, and the efficacy of precision medicine and drug discovery processes is boosted, ultimately resulting in the development of superior medicines and diagnostic tools tailored for individual patients. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit body, disclosed that the FDA sanctioned 16 novel personalized treatments for rare disease patients in 2023, marking a considerable rise from the six approved in 2022. Consequently, the expanding requirement for precision medicine is propelling the advancement of lab automation within the drug discovery market.

Which Segment Areas Are Covered In The Lab Automation In Drug Discovery Market Analysis?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

What Key Developments And Trends Are Impacting The Lab Automation In Drug Discovery Market?

Leading companies active in the lab automation segment within the drug discovery market are incorporating AI-driven and robotics-based platforms to accelerate formulation development and enhance R&D efficiency. These advanced AI-powered and robot-assisted platforms utilize smart algorithms and automated machines to streamline various tasks, boost precision, and speed up workflows. As an illustration, in May 2025, Intrepid Labs, a Canada-based research laboratory, launched its Valiant platform, an AI-driven and robotics-enabled system engineered to dramatically accelerate drug formulation development. Supported by more than $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company intends to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant autonomously explores full formulation design spaces, effectively reducing timelines from months to days while improving therapeutic performance and safety. Since its founding in 2023, Intrepid Labs has secured partnerships with major pharmaceutical companies and CROs, and is additionally developing proprietary oral and long-acting injectable technologies for licensing.

Which Global Companies Are Actively Competing In The Lab Automation In Drug Discovery Market?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

Read the full lab automation in drug discovery market report here:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Lab Automation In Drug Discovery Market?

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lab Automation In Drug Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2026, By The Business Research Company

Lab Automation In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Lab Automation In Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-genomics-global-market-report

Lab Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the lab automation in drug discovery market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Lab Automation In Drug Discovery Market?

The market for lab automation in drug discovery has shown robust expansion in recent years. This market is projected to expand from $6.77 billion in 2025 to $7.12 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.1%. Historically, this growth has been driven by factors such as the incorporation of robotic arms in laboratory settings, a surge in pharmaceutical research and development investments, a heightened need for automation to minimize errors, the implementation of lab information management systems, and advancements in high-throughput screening technologies.

The market size for lab automation in drug discovery is projected to experience substantial growth in the upcoming years. It is forecast to expand to $8.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.2%. This growth during the forecast period can be attributed to the increasing prevalence of AI-driven drug discovery platforms, a growing demand for personalized medicine, the expansion of cloud-based lab management solutions, the integration of advanced robotics for sample handling, and a rise in collaborations between pharmaceutical and biotechnology companies. Significant trends expected during the forecast period include automated high-throughput screening, integrated laboratory workflows, the use of predictive analytics in drug discovery, the miniaturization of laboratory processes, and cloud-based lab management systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

What Drivers Are Supporting Technological Adoption In The Lab Automation In Drug Discovery Market?

The rising need for precision medicine is anticipated to fuel the expansion of lab automation in the drug discovery market moving forward. Precision medicine, alternatively termed personalized medicine, involves a strategy for medical treatment and prevention that considers each person’s unique variations in genes, environment, and lifestyle. Lab automation expedites research, enhances experimental consistency, and improves the effectiveness of precision medicine and drug discovery workflows, ultimately contributing to the development of more efficacious medications and diagnostics tailored to individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, announced that in 2023, the FDA granted approval to 16 new personalized treatments for patients with rare diseases, representing a substantial rise from the six approved in 2022. As a result, the escalating demand for precision medicine is propelling the growth of lab automation within the drug discovery market.

What Segment Types Are Examined In The Lab Automation In Drug Discovery Market?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

What Trends Are Projected To Support The Growth Of The Lab Automation In Drug Discovery Market?

Leading companies active in the drug discovery lab automation market are concentrating on integrating AI-driven and robotics-based systems to accelerate the development of formulations and enhance R&D productivity. AI-powered and robot-assisted platforms leverage smart algorithms and automated equipment to streamline operations, increase precision, and expedite workflows. As an illustration, in May 2025, Intrepid Labs, a Canada-based research facility, launched its Valiant platform, an AI-driven and robotics-enabled system engineered to dramatically speed up drug formulation development. Supported by more than $11 million in total funding, which includes a recent $7 million seed round led by AVANT BIO, the company’s objective is to substitute slow, trial-and-error formulation processes with swift, data-driven optimization. Valiant autonomously explores entire formulation design spaces, cutting timelines from months to days while simultaneously improving therapeutic performance and safety. Since its establishment in 2023, Intrepid Labs has secured partnerships with major pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.

Who Are The Prominent Global Companies Shaping The Lab Automation In Drug Discovery Market Landscape?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Lab Automation In Drug Discovery Market?

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lab Automation In Drug Discovery Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2026, By The Business Research Company

Lab Automation In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Lab Automation In Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-genomics-global-market-report

Lab Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the lab automation in drug discovery market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Lab Automation In Drug Discovery Market Now And By 2029?

The lab automation in drug discovery market has experienced consistent growth in recent years. Its expansion is projected from $6.47 billion in 2024 to reach $6.77 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 4.7%. Historically, this growth can be ascribed to factors such as the increasing intricacy of drug discovery processes, the imperative for enhanced efficiency and reduced costs, the expanding requirement for high-throughput screening, escalating labor expenses, and the urgency to expedite drug development schedules.

The lab automation in drug discovery market size is set for significant expansion over the next few years, projected to reach $8.28 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.2%. This growth throughout the forecast period stems from factors such as the broadening drug pipelines of pharmaceutical companies, an increase in personalized medicine and precision therapeutics, a heightened focus on rare diseases and orphan drugs, the demand for remote and decentralized clinical trials, and the advancement of microfluidics and lab-on-a-chip technologies. Notable trends during this period encompass the widespread availability of modular and customizable automation solutions, the integration of cloud-based platforms for data management and collaboration, the spread of automation in developing markets, the emergence of virtual drug discovery companies utilizing automation and digital solutions, and the establishment of standardized protocols and interoperable systems.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

Which Long-Term Drivers Are Expected To Sustain The Lab Automation In Drug Discovery Market?

The rising need for precision medicine is projected to boost the expansion of lab automation within the drug discovery market in the future. This medical strategy, also termed personalized medicine, focuses on treatment and prevention by considering each individual’s unique genetic makeup, environmental factors, and lifestyle. By enhancing research speed, boosting experimental reproducibility, and optimizing the effectiveness of precision medicine and drug discovery processes, lab automation ultimately contributes to developing better medicines and diagnostics tailored for individual patients. For example, data from October 2022, released by the Personalized Medicine Coalition (PMC), a US-based organization dedicated to advancing the comprehension and implementation of personalized medicine, indicated that over 75,000 genetic testing products and 300 personalized medicines would be available in the market to address multiple types of cancer, genetic rare diseases, and various chronic and infectious diseases. Consequently, the growing requirement for precision medicine is fueling the growth of lab automation within the drug discovery market.

How Is The Lab Automation In Drug Discovery Market Classified By Different Segments?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

What Current And Upcoming Trends Are Shaping The Lab Automation In Drug Discovery Market?

Major companies operating in lab automation in the drug discovery market are increasingly focusing on developing sophisticated solutions, such as rapid idea-to-data solutions, to gain a competitive advantage. A rapid idea-to-data solution refers to an optimized process or platform that allows individuals or organizations to quickly transform their ideas or concepts into actionable insights or data-driven results. For instance, in April 2022, Strateos Inc., a US-based biotechnology company, introduced a rapid idea-to-data solution for small molecule discovery on its cloud lab automation-as-a-service platform. This is a lab automation tool specifically designed for small-molecule discovery in drug development. The on-demand, scalable Strateos Cloud Lab Automation-as-a-Service Platform incorporates linked robotic automation with 23 workcells and hundreds of instruments. The platform facilitates early lead generation through lead optimization, orchestrated by a software architecture that allows users to design compounds of interest in the cloud and have them automatically assembled and tested using a variety of methods such as cell-based, biochemical, and structured-activity relationship (SAR) assessments.

Who Are The Primary Market Leaders In The Lab Automation In Drug Discovery Market?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Lab Automation In Drug Discovery Market?

North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2025, By The Business Research Company

Robotics And Automation Actuators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/robotics-and-automation-actuators-global-market-report

Automation As A Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automation-as-a-service-global-market-report

Automation Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automation-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model